| | | | ACS | 42% 45% | | 2017 7 | 47% 28% | | | | | | | 19 | | 1. D | D | | 10 15 | | | | 2. 9 | 20% | 14% | | | | 30 9 | | | 3. 30 30 5 | | | | | | | 30% | | | 4. | | | 15 | | | | | 40% | 5. | | | | | | | | | 6. | | | | 30% | | | 7. | | | | | | | | | | | 8. | | | | CT | | 55 | | | | | 95% | | | 50 | | 9. | | | | 5 | 90% 95% | 10. | | | | 40 | | BRCA1 BRCA2 | | | 94% | 40% 77% | | 11. X | | 25 | X | | | | 12. | 3.8 | | | | | | | 13. 19 | | 67% | | | 14. | 6. | 1 4 6 | 54% | | | | | | | 15. | | | | | | 16. | | | | 2 | 3 | 10 | 15 | | 17. | 4 | 5 | 36% | | | | 18. | | 52% | | | | 19. | | | | | | | | | | | | | | | | B | | | | | | 4 | 54% | | | | | | | | 9 | | 24% | | | B6 | | 39% | | | | | | | | | | | | | | | | | | 2.5 | | | 140 | | | 13 | | 42% 27% | 26% 23% | | 22% | 21% 20% | 17% 16% | 15% 13% | 13% 10% |